SML3068

PSEM308 hydrochloride

≥98% (HPLC)

• Synonym(e): 5-Methyl-3,4,14-triazapentacyclo[12.2.2.14,7.02,13.011,19]nonadeca-2,7(19),8,10-tetraene hydrochloride, 5-Methyl-5,8,9,10,11a,12-hexahydro-4H-8,11-ethanopyrido[3′,2′:3,4]diazepino[6,7,1-hi]indole hydrochloride, PSEM 308 hydrochloride, PSEM308 hydrochloride, Pharmacologically selective effector molecule 308, hydrochloride
• Empirische Formel (Hill-System): C₁₇H₂₁N₃ · HCl
• Molekulargewicht: 303.83
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD31689250
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear (warmed)
• storage temp.: 2-8°C
• SMILES string: CC1CC2=CC=CC3=C2N1N=C(C4CCN5CC4)C5C3.Cl

Beschreibung

Biochem/physiol Actions

PSEM agonist for chimeric ligand-gated ion channel pores with nAChR ?7 LBD L141F or L141F/Y115F mutant (PSAM) in vitro and in vivo.

SEM308 is a pharmacologically selective effector molecule (PSEM) that acts as a selective agonist in vitro and in vivo for chimeric pharmacologically selective actuator modules (PSAMs) composed of nAChR α7 ligand-binding domain (LBD) with L141F or L141F/Y115F mutation fused to the ion pore domain (IPD) of a ligand-gated ion channel (LGIC), including glycine receptor (PSAM^L141F-GlyR & PSAM^{L141F/Y115F-GlyR}) and 5-HT3 (PSAM^{L141F/Y115F-5-HT3}).

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable